- Berita Terkini
- Produk
- Perusahaan
- Penelitian
- Peluang Karir
- Internasional
- Servier Medical Art
Anda di sini
Servier and CTI Biopharma Announce Exclusive License and Collaboration Agreement to Develop and Commercialize Pixuvri
|
|
Suresnes, France, September 17, 2014 - Servier and CTI BioPharma Corp. (CTI) (NASDAQ and MTA:CTIC) today jointly announced and they have entered into and exclusive license and collaboration agreement to develop and commercialize PIXUVRI® (pixantrone). Silahkan klik di sini untuk informasi lebih detail. |
|
Contact : CTI BioPharma Contact
Monique Greer
+1 206-272-4343
Servier Contact
Servier Communication Department
+33 1 5572 6037
Email : presse@servier.fr
-----------------------------------------------------------
|
- English
- Bahasa Indonesia